Talloa, D.; Triarico, S.; Agresti, P.; Mastrangelo, S.; Attinà , G.; Romano, A.; Maurizi, P.; Ruggiero, A.
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. Cancers 2022, 14, 4264.
https://doi.org/10.3390/cancers14174264
AMA Style
Talloa D, Triarico S, Agresti P, Mastrangelo S, Attinà G, Romano A, Maurizi P, Ruggiero A.
BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. Cancers. 2022; 14(17):4264.
https://doi.org/10.3390/cancers14174264
Chicago/Turabian Style
Talloa, Dario, Silvia Triarico, Pierpaolo Agresti, Stefano Mastrangelo, Giorgio Attinà , Alberto Romano, Palma Maurizi, and Antonio Ruggiero.
2022. "BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors" Cancers 14, no. 17: 4264.
https://doi.org/10.3390/cancers14174264
APA Style
Talloa, D., Triarico, S., Agresti, P., Mastrangelo, S., Attinà , G., Romano, A., Maurizi, P., & Ruggiero, A.
(2022). BRAF and MEK Targeted Therapies in Pediatric Central Nervous System Tumors. Cancers, 14(17), 4264.
https://doi.org/10.3390/cancers14174264